I haven't written a post this sad since I was at the height of writing up the stories of #Burzynski patients. Unfortunately, @019Clinica produces a lot of these cases, and they need to be discussed in part 3. 1/https://sciencebasedmedicine.org/clinica-0-19-false-hope-in-monterrey-for-brain-cancer-patients-part-3-of-3/ …
-
Show this thread
-
I also notice that in response to my posts the
@019Clinica doctors at Instituto de Oncología Intervencionista has posted a new page of "Myths and Realities." These are all a lot of straw men. 2/ https://www.idoimexico.com/myths2 replies 3 retweets 6 likesShow this thread -
The cllaim of the
@019Clinica doctors that most interests me, though, is that they have published "Super-selectiveintraarterial chemotherapy in the primary management of diffuse intrinsic pontine glioma: 2-year experience from an institution in México.” 3/2 replies 3 retweets 6 likesShow this thread -
According to
@019Clinica, this abstract was published "in the framework of the XII Congress of Latin American Immunology (ALAI) and the XXIII Congress of the Mexican Immunology Society (SMI)." 4/1 reply 3 retweets 3 likesShow this thread -
Just to let
@019Clinica docs, Drs. Siller and Garcia know, I will be getting my hands on a copy of that abstract. They could save me the trouble by emailing it to me (preferably with the poster or slides from their presentation), but somehow I doubt they'll do it. 5/2 replies 3 retweets 12 likesShow this thread
So far no response. And that abstract is damned difficult to find. It's almost as though @019Clinica wanted it to be very hard to find: Present at an obscure conference as a late abstract not included in the abstract book...hmmm. 
-
-
Replying to @gorskon @019Clinica
why would the clinic not provide you with a copy directly?
#transparency#openness0 replies 0 retweets 1 likeThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.